1. 2022-RA-459-ESGO UPLIFT (ENGOT-ov67/GOG-3048) a registrational trial of Upifitamab Rilsodotin (XMT-1536; UpRi), a NaPi2b-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer. (20th October 2022) Authors: Concin, Nicole; Monk, Bradley J; Mirza, Mansoor Raza; Coleman, Robert L; Ray-Coquard, Isabelle; Pothuri, Bhavana; Baurain, Jean-Francois; Alejandro Perez-Fidalgo, J; Cibula, David; Saverse, Antonella; Banerjee, Susana; Madry, Radek; Marth, Christian; Putiri, Emily; Barrett, Jamie; DeMars, Leslie;... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗